This graph is a good visual depiction of how aging baby boomers, advances in technology and shifts in the way healthcare is delivered under reform may influence jobs in the healthcare sector.
In a Labor Day article, PBS directed us to interesting data published last year by U.S. Bureau of Labor Statistics in its Occupational Outlook Handbook (h/t @VentureValkyrie). Seventeen of the 30 occupations expected to grow the quickest between 2010 and 2020 are healthcare and medicine-related.
A person who has suffered from a stroke or spinal-cord injury might need to use crutches or a wheelchair as they gradually regain lost motion through physical therapy.
But these patients could see drastically different effects strapping on a robotic bodysuit or a bionic limb and walking around like Iron Man as they heal. And such digital hardware has the potential to make them recover faster, as well.
This is the thinking at several privately held medical robotics companies, several of whom are planning major roll-outs of the technology to thousands of rehabilitation clinics nationwide, and even the home. Price points are coming down while demand among physical therapists is beginning to rise, several company founders say.
Nearly one-third of the 36 emerging technology pioneers chosen by the World Economic Forum this year have implications for the life sciences and health IT space. They represent robotics, noninvasive prenatal testing, using edible identifiers to guard against counterfeit drugs and an anti-smoking vaccine.
Since 2000, the World Economic Forum has identified companies based on their potential to make a global impact with the groundbreaking technology they’ve developed. Here are 11 of the companies.
Electronic medical records. DNA sequencing. Big data. These technology trends are changing the way medicine is practiced today — but what’s coming next?
I scoured the web, reached out to futurists and drew from past conversations with industry leaders to compile a list of the next generation of disruptive technologies that are on the brink of breaking through in healthcare. What’s missing from this list?
In early human tests, SetPoint Medical has found that an electronic implant helped reduce the symptoms of rheumatoid arthritis in six of eight patients. The company, which is based in Valencia, California, is one of many groups exploring the potential of electronic implants to treat diseases by delivering pulses to nerves that regulate organ or body functions.
Israel-based Oxitone has created a wristwatch that measures heart rate and blood oxygen levels, delivering the data instantly to medical professionals.
The European Commission plans to combat many obesity and nutrition-linked lifestyle diseases, such as hypertension, diabetes and certain cancers, by reducing the content of sugar, salt or trans-fat in processed food without using additives.
As the obesity epidemic spreads across Europe, popular fast food such as frozen pizza continues to contain too much sugar, salt or fat. To try to curb the trend, the Commission set up a strategy for tackling the problem back in 2007.
But substitutes that replaces sugar, such as the low-calorie sweetener aspartame, have come under scrutiny themselves.
A new mobile health trends report released Wednesday underscores the mid- to low sophistication of current mHealth application technology but also emphasizes the explosive growth and integration headed for the market . The Research and Markets mHealth trends report shows the industry poised for a compound annual growth rate of 61 percent by 2017, to reach a value of $26 billion.
Hoy comentamos en este espacio una interesante infografía de la compañía MeMd dedicada a 8 tecnologías innovadoras cuya contribución puede ser decisiva para la eSalud, mejorando la atención sanitaria y reduciendo costes. La eSalud está demostrando ser una herramienta clave en la transformación y modernización de la atención sanitaria y soluciones como las señaladas por esta infografía tienen mucho que ver en ello:
The European medical technology industry worries that a centralised pre-market authorisation system in Europe will destroy innovation, research and development within the sector. It warns especially that small and medium-sized enterprises (SMEs) could disappear with the proposed new system.
The industry said SMEs will not benefit from the proposed system, warning that they are the ones doing most of the groundwork when it comes to inventing new cutting-edge technologies which can save the life of patients.
The European Commission has tabled new rules for the approval of medical devices following a health scandal in France involving faulty breast implants.
